Kingworld Medicines Group Ltd
HKEX:1110
Kingworld Medicines Group Ltd
Cash from Operating Activities
Kingworld Medicines Group Ltd
Cash from Operating Activities Peer Comparison
Competitive Cash from Operating Activities Analysis
Latest Figures & CAGR of Competitors
Company | Cash from Operating Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Kingworld Medicines Group Ltd
HKEX:1110
|
Cash from Operating Activities
¥42.3m
|
CAGR 3-Years
-30%
|
CAGR 5-Years
-7%
|
CAGR 10-Years
N/A
|
|
Sinopharm Group Co Ltd
HKEX:1099
|
Cash from Operating Activities
¥17.2B
|
CAGR 3-Years
15%
|
CAGR 5-Years
36%
|
CAGR 10-Years
13%
|
|
Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607
|
Cash from Operating Activities
¥2.4B
|
CAGR 3-Years
-28%
|
CAGR 5-Years
-6%
|
CAGR 10-Years
14%
|
|
Jointown Pharmaceutical Group Co Ltd
SSE:600998
|
Cash from Operating Activities
¥4.1B
|
CAGR 3-Years
5%
|
CAGR 5-Years
18%
|
CAGR 10-Years
N/A
|
|
C
|
China National Medicines Corp Ltd
SSE:600511
|
Cash from Operating Activities
¥2.2B
|
CAGR 3-Years
20%
|
CAGR 5-Years
84%
|
CAGR 10-Years
27%
|
Huadong Medicine Co Ltd
SZSE:000963
|
Cash from Operating Activities
¥3.7B
|
CAGR 3-Years
2%
|
CAGR 5-Years
11%
|
CAGR 10-Years
25%
|
See Also
What is Kingworld Medicines Group Ltd's Cash from Operating Activities?
Cash from Operating Activities
42.3m
CNY
Based on the financial report for Dec 31, 2023, Kingworld Medicines Group Ltd's Cash from Operating Activities amounts to 42.3m CNY.
What is Kingworld Medicines Group Ltd's Cash from Operating Activities growth rate?
Cash from Operating Activities CAGR 5Y
-7%
Over the last year, the Cash from Operating Activities growth was -77%. The average annual Cash from Operating Activities growth rates for Kingworld Medicines Group Ltd have been -30% over the past three years , -7% over the past five years .